Provided by Tiger Fintech (Singapore) Pte. Ltd.

Regeneron Pharmaceuticals

573.45
-37.1900-6.09%
Post-market: 555.17-18.2830-3.19%19:58 EDT
Volume:1.55M
Turnover:908.01M
Market Cap:62.69B
PE:14.96
High:612.99
Open:610.65
Low:572.00
Close:610.64
Loading ...
Mar 15, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 01, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 27, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 27, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 27, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 23, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 23, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 23, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 15, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 09, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 09, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 09, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 09, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 09, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 08, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 08, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 08, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 06, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 05, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]